Published in Drugs on January 01, 1990
Multiple calcium channels and neuronal function. Science (1987) 3.59
Calcium dependence of toxic cell death: a final common pathway. Science (1979) 3.35
Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab (1981) 3.18
Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol (1986) 3.18
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci (1988) 3.13
Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab (1989) 1.92
Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem (1985) 1.71
The role of calcium in cell death. Life Sci (1981) 1.57
Calcium and ischemic injury. N Engl J Med (1986) 1.54
Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA) Magn Reson Med (1991) 1.50
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system. Mol Pharmacol (1986) 1.08
The interaction of [3H]PY 108-068 and of [3H]PN 200-110 with calcium channel binding sites in rat brain. J Neural Transm (1984) 0.91
Effects of calcium antagonists on high-energy phosphates in ischemic rat brain measured by 31P NMR spectroscopy. Magn Reson Med (1987) 0.84
The regulation of intracellular calcium. Adv Exp Med Biol (1982) 0.81
Correlation of local cerebral blood flow, glucose utilization, and tissue pH following a middle cerebral artery occlusion in the rat. Stroke (1985) 0.81
Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals. Am J Med (1989) 0.81
Calcium antagonists for reduction of brain damage in stroke. J Cardiovasc Pharmacol (1990) 0.80
Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. Stroke (1987) 0.80
Dihydropyridine calcium antagonists reduce the consumption of high-energy phosphates in the rat brain. A study using combined 31P/1H magnetic resonance spectroscopy and 31P saturation transfer. J Pharmacol Exp Ther (1989) 0.80
Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals. Am J Med (1989) 0.79
Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists. Neurochem Pathol (1989) 0.78
Barbiturate protection in tolerant and nontolerant hypoxic mice: comparison with hypothermic protection. Anesthesiology (1979) 0.76
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet (2005) 4.88
Editorial peer review for improving the quality of reports of biomedical studies. Cochrane Database Syst Rev (2007) 4.12
Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev (2006) 2.59
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51
MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med (2003) 1.21
Quantitative and qualitative assessment of articular cartilage in the goat knee with magnetization transfer imaging. Magn Reson Imaging (2001) 1.21
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med (2001) 1.10
Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat. Exp Brain Res (2000) 1.07
In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed (2002) 1.05
Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function. J Biol Chem (1993) 1.05
Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI. Magn Reson Imaging (2000) 1.03
Phylogeography of the West Indian manatee (Trichechus manatus): how many populations and how many taxa? Mol Ecol (1998) 1.00
Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev (2004) 0.95
Calculation of dose coefficients for radionuclides produced in a spallation neutron source utilizing NUBASE and the evaluated nuclear structure data file databases. Health Phys (2006) 0.94
Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther (1999) 0.92
Susceptibility to cerebral infarction in the stroke-prone spontaneously hypertensive rat is inherited as a dominant trait. Stroke (1998) 0.90
Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents. NMR Biomed (1999) 0.88
From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anat Rec (2001) 0.88
Strain-dependent drug effects in rat middle cerebral artery occlusion model of stroke. J Pharmacol Exp Ther (1995) 0.85
Signal changes in the spinal cord of the rat after injection of formalin into the hindpaw: characterization using functional magnetic resonance imaging. Proc Natl Acad Sci U S A (1997) 0.84
Effect of gamma radiation on native endolithic microorganisms from a radioactive waste deposit site. Radiat Res (1999) 0.84
Magnetic resonance imaging for the evaluation of rejection of a kidney allograft in the rat. Transpl Int (1996) 0.84
Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. Magn Reson Imaging (2000) 0.84
Effects of calcium antagonists on high-energy phosphates in ischemic rat brain measured by 31P NMR spectroscopy. Magn Reson Med (1987) 0.84
Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRI. NMR Biomed (2000) 0.83
Quantification of optic nerve blood flow changes using magnetic resonance imaging. Invest Ophthalmol Vis Sci (1995) 0.83
Longitudinal in vivo imaging of bone formation and resorption using fluorescence molecular tomography. Bone (2012) 0.81
Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo. Neuropharmacology (1996) 0.81
Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn Reson Med (2001) 0.81
Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals. Am J Med (1989) 0.81
Calcium antagonists for reduction of brain damage in stroke. J Cardiovasc Pharmacol (1990) 0.80
Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. Stroke (1987) 0.80
Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy. Allergy (2011) 0.80
Pharmacological MRI: a nebulous concept. Trends Pharmacol Sci (2000) 0.80
Pharmacological inhibition of restenosis: learning from experience. Trends Pharmacol Sci (1995) 0.79
Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation (2000) 0.79
The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed (2000) 0.79
Effect of spirapril on left ventricular hypertrophy due to volume overload in rats. J Cardiovasc Pharmacol (1992) 0.79
Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals. Am J Med (1989) 0.79
Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat. Blood Press (1993) 0.78
Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imaging. J Cardiovasc Pharmacol (1993) 0.78
Chronic graft loss: dealing with the vascular alterations in solid organ transplantation. Transplant Proc (1998) 0.78
Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitors. J Med Chem (1995) 0.78
Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage. Neuropharmacology (2000) 0.78
Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists. Neurochem Pathol (1989) 0.78
Resuscitation of microorganisms after gamma irradiation. Radiat Res (1999) 0.77
Partial inhibition of the growth of transplanted dunning rat prostate tumors with the long-acting somatostatin analogue sandostatin (SMS 201-995). Cancer Res (1988) 0.77
Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRI. NMR Biomed (2001) 0.77
Preclinical models of chronic rejection: promises and pitfalls. Transplant Proc (1997) 0.76
Noninvasive 3D MR microscopy as a tool in pharmacological research: application to a model of rheumatoid arthritis. Magn Reson Imaging (1995) 0.76
A study paradigm allowing comparison of multiple high-resolution rCBV-maps for the examination of drug effects. NMR Biomed (2005) 0.76
Application of NMR imaging and spectroscopy to the pharmacology of cerebro-vascular disorders. Therapie (1987) 0.75
Video-assisted open supraclavicular sympathectomy following air embolism. JSLS (2013) 0.75
Efficacy of isradipine in middle cerebral artery-occluded rats. Stroke (1992) 0.75
SDZ ENS 163 a novel pilocarpine like drug: pharmacological in vitro and in vivo profile. Life Sci (1993) 0.75
Prevention of stroke and brain damage with calcium antagonists in animals. Am J Hypertens (1991) 0.75
In vivo pharmacokinetics using MRS. NMR Biomed (1999) 0.75
Decreased lumen size after balloon injury despite inhibition of neointimal thickening and antivasospastic treatment. Cardiovasc Res (1994) 0.75
[13C]NMR studies of the effect of the somatostatin analogue octreotide on hepatic glycogenesis and glycogenolysis. Peptides (1994) 0.75
Current awareness. NMR Biomed (2001) 0.75
Failure of isradipine in cerebral ischemia models. Stroke (1996) 0.75
Target watching with a beady eye. Nat Biotechnol (2000) 0.75
The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection. Transplant Proc (1997) 0.75
Magnetic resonance imaging of intracerebral neural grafts. Prog Brain Res (1988) 0.75
Quality assurance methods and procedures used to verify consistency in calculating dose coefficients. Health Phys (2006) 0.75
Allo- and autotransplantation of carotid artery--a new model of chronic graft vessel disease: evaluation by magnetic resonance imaging and histology. Transplantation (1997) 0.75